Increased concentrations of soluble B7-H3 and interleukin 36 in bronchoalveolar lavage fluid of Children with Mycoplasma pneumoniae pneumonia
Background The purpose of this study is to explore the correlations of interleukin 36 (IL-36) and Soluble B7-H3 (sB7-H3) levels in bronchoalveolar lavage fluid (BALF) with clinical characteristics and laboratory findings. Methods A total of 35 children with M. pneumnoiae pneumonia (MPP) and 15 contr...
Saved in:
Published in | BMC infectious diseases Vol. 16; no. 1; p. 212 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
17.05.2016
BioMed Central Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2334 1471-2334 |
DOI | 10.1186/s12879-016-1555-6 |
Cover
Summary: | Background
The purpose of this study is to explore the correlations of interleukin 36 (IL-36) and Soluble B7-H3 (sB7-H3) levels in bronchoalveolar lavage fluid (BALF) with clinical characteristics and laboratory findings.
Methods
A total of 35 children with
M. pneumnoiae
pneumonia (MPP) and 15 control subjects were enrolled. BALF concentrations of sB7-H3 and IL-36 were detected using enzyme-linked immunosorbent assays and clinical profiles of children with MPP were obtained.
Results
Children with MPP had significantly higher levels of sB7-H3 and IL-36 compared to control subjects (both
P
< 0.05). Meanwhile, children with pleural effusion had significantly higher levels of sB7-H3 and IL-36 compared to children without pleural effusion (both
P
< 0.05). BALF concentration of sB7-H3 was strongly associated with concentration of IL-36 (
r
= 0.796,
P
< 0.0001) and sB7-H3 was correlated with duration of fever (
r
= 0.427,
P
= 0.11) and length of stay (
r
= 0.345,
P
= 0.043). Both concentrations of sB7-H3 and IL-36 were significantly decreased in convalescent phase after treatment (both
P
< 0.05).
Conclusion
Both soluble B7-H3 and IL-36 may play an important role in pathogenesis of
M. pneumoniae
infection and sB7-H3 could be useful as a prognostic predictor or biomarker of MPP. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1471-2334 1471-2334 |
DOI: | 10.1186/s12879-016-1555-6 |